Fulcrum Therapeutics, Inc. Common Stock
$3.74
▼ 0.04
(-1.19%)
Volume: 2,493,002
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
46
- 21d momentum -3.1%
- RSI 42
🎯
Pullback
62
- Near lower Bollinger band
- -1.8% vs 20MA
💎
Value
58
- -76% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)41.8
MACD-0.006
MA trendMixed
ATR2.14%
21d mom.-3.1%
63d mom.-1.6%
vs 20MA-1.8%
RVOL(20)1.82×
52w low · 3
52w high · 16
-76.2% from 52-week high
20d support 4
· resistance 4
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$289M
PER—
PBR0.93
PSR—
EPS$-1.11
ROE-27.4%
ROA-26.2%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-2.82
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -0.53% | -3.11% | -1.58% | -46.11% | -54.67% | -65.75% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -2.86%, daily vol 0.85%. Fulcrum Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.